The binding of growth factors to their cognate receptors at the plasma membrane elicits a variety of biochemical and genomic changes that lead ultimately to cell proliferation or to differentiation. One of the cellular responses is the transcriptional activation of immediate-early genes. While much attention has focused on the identification and characterization of these genes, the mechanisms linking receptor occupancy to their rapid and transient expression remain largely unknown. The identification of some of these transcription factors as phosphoproteins has implied the involvement of protein phosphorylation in transcriptional regulation [ 11. However, the nature of the growth-responsive kinases that participate in this process has not yet been elucidated.
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Several protein serinelthreonine kinases that participate in regulating cell growth and development have been identified recently. Among these are two distinct families of 40 S ribosomal protein S6 kinases, pp9OrSk (RSK, 90 kDa-ribosomal S6 kinase) and pp7OShk (70 kDa-ribosomal S6 kinase) [2, 31. These protein serine/threonine kinases are differentially regulated by a variety of mitogens via distinct signalling cascades [4, 51. Both enzymes are regulated by serinelthreonine phosphorylation, suggesting that protein serinelthreonine kinases exist upstream in the signalling pathways that regulate these enzymes. While the putative ~~7 0 "~~ protein kinase has not yet been identified, several studies have provided evidence that pp9OrSk is phosphorylated and activated by mitogen-activated protein kinases (MAP kinases) [6, 71 . MAP k' inases have been shown to be activated by phosphorylation both at threonine and at tyrosine residues in many types of cells in response to various extracellular stimuli [8] .
In this paper, we demonstrate that MAP kinases and RSK are localized in the nucleus as well as in the cytoplasm of cultured cells. The activated enzymes can phosphorylate several nuclear 
MAP kinase and RSK are localized in the cytoplasm and in the nucleus
MAP kinases and RSK were originally isolated as cytosolic enzymes. However, their subcellular distribution has not been characterized in detail. Antisera made against the predicted C-terminal 20 amino acids (348-367) of the erk-1-encoded MAP kinase and recombinant RSK protein were affinitypurified and used to analyse the distribution of pp44-and pp42-MAP kinases and RSK. In serum- and RSK is conserved in other cell types, such as chicken embryo fibroblasts and mouse 3T3 fibroblasts; however, a large mitogen-stimulated increase of nuclear MAP kinase and RSK was not observed consistently in all cells. In chicken embryo fibroblasts and mouse 3T3 fibroblasts, significant levels both of MAP kinase and of RSK exist in the nucleus even in quiescent cells. Like the cytoplasmic enzymes, the nuclear enzymes were growth-factorresponsive, as determined by cell fractionation analysis and specific immune complex kinase assays [9] . (Figure 2 ). In fact, these enzymes can phosphorylate c-Fos in a co-operative manner; namely, the protein phosphorylated by one enzyme becomes a better substrate for the second enzyme. Detailed two-dimensional tryptic peptide mapping of in vivo and in vitro phosphorylated c-Fos revealed that MAP kinase and RSK phosphorylate c-Fos predominantly at its major in vivo phosphorylation sites. Using biochemical approaches, the phosphorylation sites for RSK and MAP kinase were localized to serine-362 and serine-374 (rat) respectively [22] . To confirm this, site-directed mutagenesis was performed to substitute serine-362 and/or serine-374 with alanine (designated as S362A, S374A, and S362/374A in Figure 3 ). The mutant Fos proteins were expressed in and isolated from bacteria for in vitro phosphorylation and tryptic peptide mapping analysis. Wild-type Fos protein generated tryptic peptide 1' from RSK and peptides Serine-362 and serine-374 are in the C-terminal trans-repression domain of c-Fos [23] . It has been shown that repression of the c-fox gene after its induction is mediated by its own product, c-Fos, mainly through the SRE [24- 261. Inhibition of c-Fos synthesis by protein synthesis inhibitors prolongs and enhances c-fos gene expression [27, 2x1. Conversely, overexpression of c-Fos protein by a constitutive promoter diminishes transcription from the c-fos promoter [24-261. The ability of c-Fos to suppress its own promoter depends on the C-terminus of the protein, which is truncated in transrepression-deficient v-Fos [29] . Phosphorylation of the C-terminal region has been demonstrated previously to be essential for c-Fos trans-repression activity, since mutations of groups of serine residues (to alanine) in this region have been shown to result in the loss of trans-repression activity [23] . The identification of serine-362 and serine-374 as the major in vivo phosphorylation sites, and as the RSK and MAP kinase phosphorylation sites respectively, suggests that MAP kinase and RSK
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Signalling from the Plasma Membrane to the Nucleus contribute to the repression of the c-fos gene expression through the SRE.
Conclusion
The MAP kinase/RSK protein kinase cascade is the best characterized and well-studied signalling pathway. This system has been shown to be downstream to the plasma membrane-associated, protooncogene product Ras [ 30-361, linking signalling from the plasma membrane into cytoplasm. The identification and characterization of the components mediating signalling between Ras and MAP kinase is an active field of investigation at present. W e have extended further this signal transduction pathway into the nucleus, linking directly to the regulation of growth-responsive gene expression.
The observation that MAP kinase and RSK are present in the nucleus before and after mitogenstimulation in several cell types suggests that activation of pre-existing enzymes in the nucleus is responsible for their activity. This process as well as the translocation of the active enzymes from the cytoplasm in to the nucleus may be the mechanisms of nuclear signal transduction in other cell types, such as HeLa [ 101 and PC12 cells [37] . The similar activation kinetics and phosphorylation of the nuclear enzymes compared with their cytoplasmic counterparts indicate that common regulatory mechanisms are involved in these two compartments. It will be of interest to determine whether MAP kinase kinase or its upstream regulators are actually transduce signals from the cytoplasm into the nucleus via translocation upon stimulation. Since the phosphorylation and activation state of MAP kinase and RSK are balanced by upstreamactivating kinases and specific phosphatases, it is logical to speculate that the corresponding phosphatases for MAP kinase and for RSK may have a similar pattern of subcellular localization.
The identification of potential nuclear substrates for MAP kinase and for RSK provides insights in to the role of these enzymes in cell proliferation. W e have demonstrated that RSK and MAP kinase co-ordinately phosphorylate c-Fos within the C-terminal trans-repression domain, at serine-362 and serine-374 respectively. Phosphorylation in this region has been shown to be required for c-Fos to repress transcription from its own promoter, mainly through the SRE [23] . This transrepression activity of c-Fos appears to play an important role in regulating its transforming potential, since deletion at the C-terminus or mutation of groups of serine residues in this region resulted in reduced trans-repression activity and in an increase The C-terminal region of c-Fos is highly similar among Fos members, indicating a conserved nature for trans-repression activity. In fact, trans-repression activity has been reported for another two members of the Fos family, FosH [43] and Fra-1 [44] . The differential expression kinetics among the fos members indicates their function in activation and repression of transcription at different stages of the G, phase. Phosphorylation of members of the Fos protein family by MAP kinase and RSK will then provide a general means to coordinately and properly turn off the transcription of cascades of genes. De-regulation of this process by mutation, as in the case of v-Fos, will then result in the prolonged expression of growth-responsive genes that are normally expressed transiently, leading to cellular transformation. W e can thus envisage a model where the MAP kinase/RSK signalling cascade has the capacity not only to transmit growth-activating signals from the plasma membrane to the nucleus, but also to provide feedback loops to balance the mitogenic signals, ensuring a potentially important balance between the positive and negative regulatory pathways.
